AVIEAvantis Inflation Focused Equity ETF
Seeks long-term capital appreciation.
By Avantis Investors · Launched 2022
Annual Cost
0.25%
#1,230 of 5,562 · low cost
Fund Size
$10M
#4,744 of 5,562 · small
Return (1Y)Goal
+20.7%
Track Record
3 years
#2,799 of 5,562 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,104+21.0%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 34.2% of fund✓ well diversified
Berkshire Hathaway Inc
7.1%
Exxon Mobil Corp
5.0%
Eli Lilly & Co
4.5%
Procter & Gamble Co/The
3.6%
Chevron Corp
2.7%
AbbVie Inc
2.6%
UnitedHealth Group Inc
2.2%
Johnson & Johnson
2.2%
Philip Morris International Inc
2.1%
Coca-Cola Co/The
2.1%
Asset allocation
Stocks
99.7%
Cash
0.3%
By sector
Energy
28.3%
Healthcare
27.7%
Consumer Defensive
17.1%
Financial Services
14.8%
Basic Materials
10.1%
Industrials
1.5%
Real Estate
0.5%
Technology
0.1%
Other
0.1%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
9.9%Low
Year-on-year price swings
Max drawdown
-12.4%Mild
Worst peak-to-trough loss
Sharpe (3Y)
0.73Decent risk-adjusted returns
Sortino (3Y)
1.02Good downside protection
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Invests primarily in U.S. companies expected to perform well during inflation, focusing on small-cap firms with high profitability and value. The strategy includes sector selection based on historical inflation performance, with active management to adjust holdings based on market data and company characteristics.
- Inception date
- September 27, 2022
- Fund family
- Avantis Investors
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed AVIE. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19